Cerebral infarction. Cerebral infarction
Conditions
Interventions
Intervention 1: Intervention group: In the first intervention group, standardized treatment and physiotherapy, and also Dorema ammoniacum gum with a daily dose of one gram is given as an oral capsule,
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
50 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patients with focal neurological findings that have been clinically and with brain imaging have been diagnosed with ischemic stroke Ischemia is in the superior branch of middle cerebral artery Stroke attack in less than thirty days Age between 50 and 75 years First stroke attack Modified NIHSS between 4 and 20 Patient with consciousness and stable disease condition
Exclusion criteria
Exclusion criteria: Cerebral stroke of hemorrhagic type Patients suffering from systemic chronic diseases such as: uncontrolled diabetes, severe liver, cardiac, renal or pulmonary disorders or cancer Patients taking coagulants (heparin or warfarin) Patients with BMI above 35 Patients with history of acupuncture in less than a month Patients with a history of allergy to Dorema Ammoniacum Patient suffering from severe musculoskeletal or neurologic diseases before ischemic stroke Patients diagnosed with tumor or skin infections
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disability due to cerebral stroke. Timepoint: Before the intervention, After the end of the intervention. Method of measurement: MNIHSS and mRankin scales. | — |
Secondary
| Measure | Time frame |
|---|---|
| Aspartate aminotransferase. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test.;Low density lipoprotein. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test.;High density lipoprotein. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test.;Alanine aminotransferase. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test.;Blood urea nitrogen. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test.;Glycosylated hemoglobin. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test.;Triglyceride. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test.;Complete Blood Count. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test.;Fasting blood sugar. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test.;Creatinine. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test.;Partial thromboplastin time. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test.;Prothrombin Time. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test.;International Normalized Ratio (INR). Timepoint: before intervention and after the end of intervention. Method of measurement: blood test.;Cholesterol. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahsa Mehrpour
Mashhad University of Medical Sciences
Outcome results
None listed